Verify Adjustment Rate, Review Pricing Rule with Cost-Benefit Standpoint: CEFP

Members of the government’s Council on Economic and Fiscal Policy (CEFP) submitted a proposal on November 25 calling for the review of drug pricing systems considering cost-effectiveness and the verification of the current 2% adjustment rate towards the 2022 reimbursement...read more